Reports for MINT PHARMACEUTICALS INC

Company Name
MINT PHARMACEUTICALS INC

Shortage reports

Actual shortage:

23 (15%)

Anticipated shortage:

0 (0%)

Avoided shortage:

1 (1%)

Resolved:

125 (84%)

149

Discontinuation Reports

To be discontinued:

0 (0%)

Discontinued:

29 (100%)

Reversed:

0 (0%)

29

34 (19%)

17 (74%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-TOPIRAMATE 100MG TABLET Resolved 2024-01-29 2024-12-05 217684
MINT-TOPIRAMATE 100MG TABLET Resolved 2017-11-07 2018-01-04 28570
MINT-TOPIRAMATE 25MG TABLET Resolved 2024-01-29 2024-03-26 217681
MINT-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2019-10-09 2019-12-10 95944
MINT-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2026-02-09 2026-02-09 277593
MINT-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2026-02-09 2026-02-09 277596
MINT-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2026-02-09 2026-02-09 277599
MINT-ZOLMITRIPTAN 2.5MG TABLET Resolved 2020-04-25 2024-12-05 113199
MINT-ZOPICLONE 5MG TABLET Resolved 2020-07-13 2020-11-03 120139

Showing 141 to 149 of 149

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13553
MINT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13544
MINT-ROSUVASTATIN 40MG TABLET Discontinued 2019-10-09 2019-10-10 95907
MINT-ROSUVASTATIN 20MG TABLET Discontinued 2019-10-09 2019-10-10 95903
MINT-ROSUVASTATIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95900
MINT-ROSUVASTATIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95897
MINT-SOLIFENACIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95913
MINT-SOLIFENACIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95916
MINT-ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13540

Showing 21 to 29 of 29